BIOMAT Database Logo BIOMAT Database Logo

In vitro anti-Cryptococcus activity of diphenyl diselenide alone and in combination with amphotericin B and fluconazole. 2021

Jéssica Louise Benelli, and Vanice Rodrigues Poester, and Lívia Silveira Munhoz, and Gabriel Baracy Klafke, and David A Stevens, and Melissa Orzechowski Xavier
Mycology Laboratory, College of Medicine, Federal University of Rio Grande, Campus Saúde, Visconde de Paranaguá 102, Centro, Rio Grande, Rio Grande do Sul, 96201-900, Brazil.

Cryptococcus is an encapsulated yeast that causes fungal meningitis, most commonly in HIV patients, with high mortality rates. Thus, the study of new treatment options is relevant. Antifungal activity of organoselenium compounds attributed to their pro-oxidative effect in fungal cells has been shown given that few data regarding its anti-Cryptococcus activity are available, this in vitro study was conducted with 40 clinical isolates of Cryptococcus neoformans. Diphenyl diselenide (DD) alone, and its interaction with amphotericin B or fluconazole, was tested by microdilution and checkerboard assays. All Cryptococcus neoformans were inhibited by DD in concentrations ≤ 32 μg/mL, and fungicidal concentrations were ≤ 64 μg/mL. Advantageous interaction between fluconazole occurred in 40% of the isolates, respectively. This study contributes with data of DD alone and in combination with classical drugs of choice for cryptococcosis treatment. Further studies focused on DD antifungal mechanism of action, and in vivo experiments are necessary.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D003453 Cryptococcosis Fungal infection caused by genus CRYPTOCOCCUS. C gattii Infection,C neoformans Infection,C. gattii Infection,C. neoformans Infection,Cryptococcus Infection,Cryptococcus Infections,Cryptococcus gattii Infection,Torulosis,Cryptococcus neoformans Infection,C gattii Infections,C neoformans Infections,C. gattii Infections,C. neoformans Infections,Cryptococcoses,Cryptococcus gattii Infections,Cryptococcus neoformans Infections,Infection, C gattii,Infection, C neoformans,Infection, C. gattii,Infection, C. neoformans,Infection, Cryptococcus,Infection, Cryptococcus gattii,Infection, Cryptococcus neoformans,Infections, C gattii,Infections, C. neoformans,Toruloses
D003455 Cryptococcus neoformans A species of the fungus CRYPTOCOCCUS. Its teleomorph is Filobasidiella neoformans. Blastomyces neoformans,Debaryomyces neoformans,Filobasidiella neoformans,Lipomyces neoformans,Saccharomyces neoformans,Torula neoformans,Torulopsis neoformans,Cryptococcus neoformans var. grubii
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001555 Benzene Derivatives Organic compounds derived from BENZENE. Derivatives, Benzene
D015725 Fluconazole Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. Apo-Fluconazole,Béagyne,Diflucan,Fluc Hexal,FlucoLich,Flucobeta,Fluconazol AL,Fluconazol AbZ,Fluconazol Stada,Fluconazol von ct,Fluconazol-Isis,Fluconazol-ratiopharm,Flunazul,Fungata,Lavisa,Loitin,Neofomiral,Oxifungol,Solacap,Triflucan,UK-49858,Zonal,Apo Fluconazole,Fluconazol Isis,Fluconazol ratiopharm,UK 49858,UK49858
D016566 Organoselenium Compounds Organic compounds which contain selenium as an integral part of the molecule. Compounds, Organoselenium

Related Publications

Jéssica Louise Benelli, and Vanice Rodrigues Poester, and Lívia Silveira Munhoz, and Gabriel Baracy Klafke, and David A Stevens, and Melissa Orzechowski Xavier
Antifungal activities of diphenyl diselenide alone and in combination with fluconazole or amphotericin B against Candida glabrata.
August 2013, Mycopathologia,
Jéssica Louise Benelli, and Vanice Rodrigues Poester, and Lívia Silveira Munhoz, and Gabriel Baracy Klafke, and David A Stevens, and Melissa Orzechowski Xavier
In vitro combination between antifungals and diphenyl diselenide against Cryptococcus species.
June 2019, Mycoses,
Jéssica Louise Benelli, and Vanice Rodrigues Poester, and Lívia Silveira Munhoz, and Gabriel Baracy Klafke, and David A Stevens, and Melissa Orzechowski Xavier
In Vitro Activity of Ebselen and Diphenyl Diselenide Alone and in Combination with Drugs against Trichophyton mentagrophytes Strains.
May 2022, Pharmaceutics,
Jéssica Louise Benelli, and Vanice Rodrigues Poester, and Lívia Silveira Munhoz, and Gabriel Baracy Klafke, and David A Stevens, and Melissa Orzechowski Xavier
In vitro activity of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Trichosporon asahii.
May 2019, Mycoses,
Jéssica Louise Benelli, and Vanice Rodrigues Poester, and Lívia Silveira Munhoz, and Gabriel Baracy Klafke, and David A Stevens, and Melissa Orzechowski Xavier
Antifungal activity of diphenyl diselenide alone and in combination with itraconazole against Sporothrix brasiliensis.
April 2019, Medical mycology,
Jéssica Louise Benelli, and Vanice Rodrigues Poester, and Lívia Silveira Munhoz, and Gabriel Baracy Klafke, and David A Stevens, and Melissa Orzechowski Xavier
Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole.
January 2000, Chemotherapy,
Jéssica Louise Benelli, and Vanice Rodrigues Poester, and Lívia Silveira Munhoz, and Gabriel Baracy Klafke, and David A Stevens, and Melissa Orzechowski Xavier
Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans.
January 2012, Medical mycology,
Jéssica Louise Benelli, and Vanice Rodrigues Poester, and Lívia Silveira Munhoz, and Gabriel Baracy Klafke, and David A Stevens, and Melissa Orzechowski Xavier
In-vitro activity of SCH39304 in comparison with amphotericin B and fluconazole.
February 1990, The Journal of antimicrobial chemotherapy,
Jéssica Louise Benelli, and Vanice Rodrigues Poester, and Lívia Silveira Munhoz, and Gabriel Baracy Klafke, and David A Stevens, and Melissa Orzechowski Xavier
In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia.
June 2004, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Jéssica Louise Benelli, and Vanice Rodrigues Poester, and Lívia Silveira Munhoz, and Gabriel Baracy Klafke, and David A Stevens, and Melissa Orzechowski Xavier
Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
April 2006, Indian journal of pathology & microbiology,
Copied contents to your clipboard!